Cochrane · systematic review · CD000406
Oral calorie supplements for cystic fibrosis
Smyth, RL, Rayner, O · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
Cystic Fibrosis and Genetic DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 14.3%Low 4 · 57.1%Moderate 2 · 28.6%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings
Population: adults and children with cystic fibrosis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Change in weight (kg):1 at 12 months | no estimate extracted | 1 study · 102 participants | Moderate Downgraded: risk of bias, imprecision, indirectness |
Change in height (cm):1 at 12 months | no estimate extracted | 1 study · 102 participants | Moderate Downgraded: risk of bias, imprecision, indirectness |
Change in total calories (Kcal/day): at 12 months | no estimate extracted | 1 study · 58 participants | Low Downgraded: risk of bias, imprecision, indirectness |
Change in total protein (g/day): at 12 months | no estimate extracted | 1 study · 58 participants | Low Downgraded: risk of bias, imprecision, indirectness |
Change in total fat (g/day): at 12 months | no estimate extracted | 1 study · 58 participants | Low Downgraded: risk of bias, imprecision, indirectness |
Adverse events: | no estimate extracted | 1 study · 1 participants | Very low Downgraded: risk of bias, imprecision, indirectness |
Change in lung function ‐ FEV₁ (% predicted): at 12 months | no estimate extracted | 1 study · 70 participants | Low Downgraded: risk of bias, imprecision, indirectness |